Scholar Rock Holding Corp (SRRK)
27.50
+0.12
(+0.44%)
USD |
NASDAQ |
Nov 14, 16:00
27.00
-0.50
(-1.82%)
Pre-Market: 09:27
Scholar Rock Net Income (TTM): -203.85M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -203.85M |
| March 31, 2024 | -183.26M |
| December 31, 2023 | -165.79M |
| September 30, 2023 | -158.92M |
| June 30, 2023 | -159.86M |
| March 31, 2023 | -165.93M |
| December 31, 2022 | -134.50M |
| September 30, 2022 | -131.16M |
| June 30, 2022 | -125.37M |
| March 31, 2022 | -112.08M |
| December 31, 2021 | -131.80M |
| September 30, 2021 | -122.46M |
| June 30, 2021 | -108.51M |
| March 31, 2021 | -97.08M |
| Date | Value |
|---|---|
| December 31, 2020 | -86.48M |
| September 30, 2020 | -71.48M |
| June 30, 2020 | -64.07M |
| March 31, 2020 | -57.32M |
| December 31, 2019 | -51.00M |
| September 30, 2019 | -54.39M |
| June 30, 2019 | -49.01M |
| March 31, 2019 | -51.19M |
| December 31, 2018 | -49.33M |
| September 30, 2018 | -42.82M |
| June 30, 2018 | -37.98M |
| March 31, 2018 | -29.16M |
| December 31, 2017 | -25.00M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-203.85M
Minimum
Jun 2024
-51.00M
Maximum
Dec 2019
-122.68M
Average
-125.37M
Median
Jun 2022
Net Income (TTM) Benchmarks
| Cytokinetics Inc | -576.40M |
| Regeneron Pharmaceuticals Inc | 4.654B |
| Ocugen Inc | -49.67M |
| Mirum Pharmaceuticals Inc | -109.16M |
| NeuroBo Pharmaceuticals Inc | -27.73M |